141 related articles for article (PubMed ID: 9022978)
1. Ligand recognition in mu opioid receptor: experimentally based modeling of mu opioid receptor binding sites and their testing by ligand docking.
Sagara T; Egashira H; Okamura M; Fujii I; Shimohigashi Y; Kanematsu K
Bioorg Med Chem; 1996 Dec; 4(12):2151-66. PubMed ID: 9022978
[TBL] [Abstract][Full Text] [Related]
2. Homology models of mu-opioid receptor with organic and inorganic cations at conserved aspartates in the second and third transmembrane domains.
Zhorov BS; Ananthanarayanan VS
Arch Biochem Biophys; 2000 Mar; 375(1):31-49. PubMed ID: 10683246
[TBL] [Abstract][Full Text] [Related]
3. [Ligand recognition in the opioid receptors by modeling methods and the design of opioids].
Kanematsu K
Yakugaku Zasshi; 1998 Jan; 118(1):1-18. PubMed ID: 9484038
[TBL] [Abstract][Full Text] [Related]
4. Exploring the structure of opioid receptors with homology modeling based on single and multiple templates and subsequent docking: a comparative study.
Bera I; Laskar A; Ghoshal N
J Mol Model; 2011 May; 17(5):1207-21. PubMed ID: 20661609
[TBL] [Abstract][Full Text] [Related]
5. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.
Pogozheva ID; Lomize AL; Mosberg HI
Biophys J; 1998 Aug; 75(2):612-34. PubMed ID: 9675164
[TBL] [Abstract][Full Text] [Related]
6. 3D modeling, ligand binding and activation studies of the cloned mouse delta, mu; and kappa opioid receptors.
Filizola M; Laakkonen L; Loew GH
Protein Eng; 1999 Nov; 12(11):927-42. PubMed ID: 10585498
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor.
Subramanian G; Paterlini MG; Portoghese PS; Ferguson DM
J Med Chem; 2000 Feb; 43(3):381-91. PubMed ID: 10669565
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling of mu opioid receptor and receptor-ligand interaction.
Rong SB; Zhu YC; Jiang HL; Zhao SR; Wang QM; Chi ZQ; Chen KX; Ji RY
Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):317-22. PubMed ID: 10072913
[TBL] [Abstract][Full Text] [Related]
9. Molecular modeling of mu opioid receptor and its interaction with ohmefentanyl.
Tang Y; Chen KX; Jiang HL; Wang ZX; Ji RY; Chi ZQ
Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):156-60. PubMed ID: 9772668
[TBL] [Abstract][Full Text] [Related]
10. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI
Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of 4-(N,N-diarylamino)piperidines with high selectivity to the delta-opioid receptor: a combined 3D-QSAR and ligand docking study.
Podlogar BL; Poda GI; Demeter DA; Zhang SP; Carson JR; Neilson LA; Reitz AB; Ferguson DM
Drug Des Discov; 2000; 17(1):34-50. PubMed ID: 10928448
[TBL] [Abstract][Full Text] [Related]
12. Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane.
Zhang P; Johnson PS; Zöllner C; Wang W; Wang Z; Montes AE; Seidleck BK; Blaschak CJ; Surratt CK
Brain Res Mol Brain Res; 1999 Oct; 72(2):195-204. PubMed ID: 10529478
[TBL] [Abstract][Full Text] [Related]
13. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.
Schiller PW; Nguyen TM; Weltrowska G; Wilkes BC; Marsden BJ; Lemieux C; Chung NN
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11871-5. PubMed ID: 1334552
[TBL] [Abstract][Full Text] [Related]
14. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
16. Comparative modeling and molecular dynamics studies of the delta, kappa and mu opioid receptors.
Strahs D; Weinstein H
Protein Eng; 1997 Sep; 10(9):1019-38. PubMed ID: 9464566
[TBL] [Abstract][Full Text] [Related]
17. Homology modeling and molecular dynamics simulations of the mu opioid receptor in a membrane-aqueous system.
Zhang Y; Sham YY; Rajamani R; Gao J; Portoghese PS
Chembiochem; 2005 May; 6(5):853-9. PubMed ID: 15776407
[TBL] [Abstract][Full Text] [Related]
18. Ligand interaction, binding site and G protein activation of the mu opioid receptor.
Cui X; Yeliseev A; Liu R
Eur J Pharmacol; 2013 Feb; 702(1-3):309-15. PubMed ID: 23415745
[TBL] [Abstract][Full Text] [Related]
19. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
[TBL] [Abstract][Full Text] [Related]
20. Multiple mu receptors: evidence for mu2 sites in the guinea pig ileum.
Gintzler AR; Pasternak GW
Neurosci Lett; 1983 Aug; 39(1):51-6. PubMed ID: 6314191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]